Sakamoto K, Yanagisawa R, Ono R, Doi T, Negishi T, Kada A, et al. Risk-stratified phase II clinical trial for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in pediatric, adolescent, and young adult patients in Japan. Pediatr Blood Cancer. 2025. https://doi.org/10.1002/pbc.32166.

Article  PubMed  Google Scholar 

Yanagisawa R, Nakazawa Y, Matsuda K, Yasumi T, Kanegane H, Ohga S, et al. Outcomes in children with hemophagocytic lymphohistiocytosis treated using HLH-2004 aprotocol in Japan. Int J Hematol. 2019;109:206–13.

Article  CAS  PubMed  Google Scholar 

Henter J-I, Samuelsson-Horne A, Aricò M, Egeler RM, Elinder G, Filipovich AH, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002;100:2367–73.

Article  CAS  PubMed  Google Scholar 

Henter J-I, Horne A, Aricó M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48:124–31.

Article  PubMed  Google Scholar 

Kimura H, Kwong Y-L. EBV viral loads in diagnosis, monitoring, and response assessment. Front Oncol. 2019;9:62.

Article  PubMed  PubMed Central  Google Scholar 

Kanakry JA, Hegde AM, Durand CM, Massie AB, Greer AE, Ambinder RF, et al. The clinical significance of EBV DNA in the plasma and peripheral blood mononuclear cells of patients with or without EBV diseases. Blood. 2016;127:2007–17.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang P, Zeng C, Cheng J, Zhou J, Gu J, Mao X, et al. Determination of Epstein-Barr virus-infected lymphocyte cell types in peripheral blood mononuclear cells as a valuable diagnostic tool in hematological diseases. Open Forum Infect Dis. 2019;6:ofz171.

Article  PubMed  PubMed Central  Google Scholar 

Zhang W, Yin Y, Li Y, Cheng L, Zhao L, Peng Y, et al. Clinical utility of plasma Epstein-Barr virus DNA monitoring in pediatric Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: a Chinese retrospective observational study. Ital J Pediatr. 2024;50:139.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Matsuda K, Nakazawa Y, Yanagisawa R, Honda T, Ishii E, Koike K. Detection of T-cell receptor gene rearrangement in children with Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis using the BIOMED-2 multiplex polymerase chain reaction combined with GeneScan analysis. Clin Chim Acta. 2011;412:1554–8.

Article  CAS  PubMed  Google Scholar 

Furui Y, Sakamoto K, Okura E, Hirabayashi K, Saito S, Yanagisawa R, et al. Dynamics of EBV-DNA load across sample types in pediatric EBV-HLH. Int J Hematol. 2025. https://doi.org/10.1007/s12185-025-04026-9.

Article  PubMed  Google Scholar 

Furui Y, Sakamoto K, Okura E, Hirabayashi K, Saito S, Yanagisawa R, et al. Persistent low-level EBV-DNA detection in non-plasma compartments during convalescence after pediatric EBV-HLH. Int J Hematol. 2026. https://doi.org/10.1007/s12185-026-04169-3.

Article  PubMed  Google Scholar 

Yanagaisawa R, Matsuda K, Ohga S, Kanegane H, Morimoto A, Okamoto Y, et al. Factors predicting the recurrence of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children after treatment using the HLH-2004 protocol. Int J Hematol. 2004;109:612–7.

Article  Google Scholar 

Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, et al. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood. 2001;98:1882–8.

Article  CAS  PubMed  Google Scholar 

Chellapandian D, Das R, Zelley K, Wiener SJ, Zhao H, Teachey DT, et al. Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens. Br J Haematol. 2013;162:376–82.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Meng G-Q, Wang J-S, Wang Y-N, Wei N, Wang Z. Rituximab-containing immuno-chemotherapy regimens are effective for the elimination of EBV for EBV-HLH with only and mainly B lymphocytes of EBV infection. Int Immunopharmacol. 2021;96:107606.

Article  CAS  PubMed  Google Scholar